Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Form 8.3

1 Dec 2025 15:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Sand Grove Capital Management LLP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Fund(s) for which Sand Grove Capital Management LLP serves as the Investment Manager or Discretionary Sub-Advisor

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Idox plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28 November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

17,541,534

3.80%

 

 

(2) Cash-settled derivatives:

 

9,039,601

1.96%

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

26,581,135

5.76%

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

1p ordinary

Purchase

1,058,669

70 GBp

 

 

 

 

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

Increasing a long position

1,241,331

70 GBp

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

No

Date of disclosure:

01 December 2025

Contact name:

James Evans

Telephone number:

+44 20 3161 0743

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251201467319/en/

Copyright Business Wire 2025

Date   Source Headline
31st Mar 20257:00 amRNS2025 AGM Trading update
18th Mar 20259:11 amRNSHolding(s) in Company
17th Mar 20257:00 amRNSEstablishment of EBT and Total Voting Rights
13th Mar 202510:48 amRNSHolding(s) in Company
10th Mar 20253:25 pmRNSHolding(s) in Company
7th Mar 20252:39 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPosting of Annual Report and Notice of AGM
24th Feb 20252:36 pmRNSHolding(s) in Company
24th Feb 20257:01 amRNSHolding(s) in Company
24th Feb 20257:00 amRNSHolding(s) in Company
19th Feb 20257:00 amRNSCorrection of payment date for dividend
10th Feb 20257:00 amRNSAppointment of Senior Independent Director
28th Jan 20257:00 amRNSFinal Results
14th Jan 20257:00 amRNSNotice of Final Results
6th Jan 20257:00 amRNS-RIdox Secures Election Services Contract in Malta
20th Dec 202410:43 amRNSHolding(s) in Company
26th Nov 20247:00 amRNSFull Year 2024 Trading Update
13th Nov 202411:55 amRNSHolding(s) in Company
12th Nov 202410:09 amRNSHolding(s) in Company
28th Oct 20244:49 pmRNSHolding(s) in Company
25th Oct 20247:16 amRNSDirectorate Change
27th Sep 20243:26 pmRNSHolding(s) in Company
25th Sep 20244:28 pmRNSHolding(s) in Company
23rd Sep 20244:00 pmRNSHolding(s) in Company
2nd Sep 20243:42 pmRNSHolding(s) in Company
21st Aug 20245:30 pmRNSExercise of Share Options & Total Voting Rights
7th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20242:51 pmRNSHolding(s) in Company
29th Jul 20247:00 amRNSDirector Appointment
11th Jun 20247:00 amRNSHalf Year Results
6th Jun 20247:00 amRNSExercise of Share Options & Total Voting Rights
24th May 20243:06 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSHalf Year 2024 Trading Update
9th May 20247:00 amRNSIssue and Allotment of Consideration Shares
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.